Search Results for "Rituximab For Scleritis"
Original Source: Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation
The purpose of this study is to assess the safety and tolerability of Rituximab in refractory scleritis and non-infectious orbital inflammation.
Matching Channels
The chimeric anti-CD20 antibody rituximab (Rituxan & MabThera) from Biogen Idec and Genentech/Roche is one of the world’s commercially most successful antibodies (2007 sales of over US$ 5 bl...
Matching News
Management of Rhodotorula scleritis
Management of Rhodotorula scleritis Eye advance online publication, September 14 2012. doi:10.1038/eye.2012.181 Authors: Z S Pradhan & P Jacob
Race for rituximab Targeting rituximab At least eight biosimilars of rituximab are on the market or in the clinic. Plans to develop four more have been announced by partners Chemo Lugano and Natco Pha...
Teva's biosimilar rituximab 'still active'
Teva Pharmaceuticals' biosimilar rituximab progam has not been terminated, or at least not yet. The generics giant told Scrip that it has "no new updates on rituximab, the project is active". This ca...
Rituximab Works for Older Mantle Cell Patients (CME/CE)
(MedPage Today) -- For older patients with mantle cell lymphoma, induction chemotherapy based on rituximab (Rituxan), followed by rituximab maintenance, offers an effective treatment, researchers repo...
Rituximab joint protective benefits capped
Study findings may help guide rituximab dosing regimens for patients with rheumatoid arthritis.
Intas launches biosimilar rituximab in India
Intas Pharmaceuticals Ltd. (Ahmedabad, India) launched Mabtas rituximab in India to treat non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) alone or in combination with chemotherapy....
BERKELEY, Calif., Dec. 31, 2012 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced it has selected active non-inf...
R-CHOP benefits older mantle-cell lymphoma patients
(HealthDay) -- In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) followed by maintena...
Matching PubMed Articles
Fungal Scleritis with Exudative Retinal Detachment.
Purpose: To report a case of fungal scleritis associated with exudative retinal detachment. Design: A rare case report. Methods: Nonresolving fungal scleritis mimicking noninfective scleritis was trea...
Ocular toxoplasmosis associated with scleritis.
We report an atypical presentation of Toxoplasma retinochoroiditis with associated scleritis in a young and immunocompetent patient. The diagnosis was done on the basis of Polymerase chain reaction of...
An update on the cause and treatment of scleritis.
PURPOSE OF REVIEW: To review new clinically relevant data regarding the cause and treatment of scleritis that has been identified over the past 36 months. RECENT FINDINGS: A recently described T-helpe...
Scleritis: When might a systemic disease be involved?
Scleritis is typically a severe painful inflammatory disorder of the eye. This process may involve the sclera but also the cornea, adjacent episclera, and underlying uvea and therefore threaten vision...
Bilateral scleritis and sclerokeratitis associated with IgA nephropathy.
PURPOSE: The purpose of this study is to report a case of bilateral nodular scleritis in a patient with final diagnosis of IgA nephropathy. METHODS: This is an observational case report. RESULTS: A ma...
